TGFβ signaling in pancreatic ductal adenocarcinoma (Q38943965)

7 September 2017

title

TGFβ signaling in pancreatic ductal adenocarcinoma (English)

1 reference

7 September 2017

1 reference

Hui Zhang

1

1 reference

7 September 2017

Chengli Liu

2

1 reference

7 September 2017

Yalin Kong

3

1 reference

7 September 2017

Hui Huang

4

1 reference

7 September 2017

Cheng Wang

5

1 reference

7 September 2017

Hongyi Zhang

6

1 reference

7 September 2017

publication date

31 October 2014

1 reference

7 September 2017

1 reference

7 September 2017

volume

36

1 reference

7 September 2017

issue

3

1 reference

7 September 2017

page(s)

1613-1618

1 reference

SnapShot: pancreatic cancer

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

TGF-beta signaling specifies axons during brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

TGFβ receptor signaling is essential for inflammation-induced but not β-cell workload-induced β-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

Basics of TGF-beta and pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

Negative regulation of TGF-beta receptor/Smad signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

Pancreatic duct cells as a source of VEGF in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

Hypoglycemia reduces vascular endothelial growth factor A production by pancreatic beta cells as a regulator of beta cell mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

Molecular basis underlying inhibition of metastasis of gastric cancer by anti-VEGFa treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

PLGF inhibition impairs metastasis of larynx carcinoma through MMP3 downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

Enhanced VEGF production and decreased immunogenicity induced by TGF-beta 1 promote liver metastasis of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

Establishment of a continuous tumor-cell line (PANC-1) from a human carcinoma of the exocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

AMP-activated protein kinase attenuates Wnt/β-catenin signaling in human osteoblastic Saos-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2757-4

Vascular endothelial growth factor

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25355597

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-014-2757-4

1 reference

Dimensions Publication ID

7 September 2017

1029901990

0 references

1 reference